Table 3.
Comparison of Adverse Effects
| EP Group (n=60) | R Group (n=60) | Total (n=120) | P value | |
|---|---|---|---|---|
| Hiccups (n, %) | 0 | 8 (13.3%) | 8 (6.7%) | 0.003 |
| Hypoxia (n, %) | 3 (5.0%) | 1 (1.7%) | 4 (3.3%) | 0.310 |
| Depression of respiration (n, %) | 6 (10.0%) | 1 (1.7%) | 7 (5.8%) | 0.051 |
| Tongue falling (n, %) | 2 (3.3%) | 1 (1.7%) | 3 (2.5%) | 0.559 |
| Total respiratory-related adverse events (n, %) | 11 (18.3%) | 3 (5.0%) | 14 (11.7%) | 0.047 |
| Choking cough (n, %) | 0 (0.0%) | 3 (5.0%) | 3 (2.5%) | 0.080 |
| Movement of the body (n, %) | 2 (3.3%) | 1 (1.7%) | 3 (2.5%) | 0.559 |
| Low blood pressure (n, %) | 22 (36.7%) | 24 (40%) | 46 (38.33%) | 0.851 |
| Nausea (n, %) | 1 (1.7%) | 1 (1.7%) | 2 (1.7%) | 1 |
| Dizziness (n, %) | 1 (1.7%) | 0 (0%) | 1 (0.8%) | 1 |